Plenary Session I

Thursday 29 November 09:30-11:15
Grand Ballroom, 2F

Time Topic Lecturer
09:30-09:45 Role of Fusion Biopsy in the Detection of Prostate Cancer  하홍구 (부산의대) 
09:45-10:00 Practical Use of Chemotherapeutic Agents in Prostate Cancer 정재영 (국립암센터)
10:00-10:15 Genes Involved in Prostate Cancer Progression Determine MRI Visibility Hyung L. Kim (Cedar Sinai Hospital, USA)
10:15-10:30 Upstaging and Upgrading in Caucasian and Korean Prostate Cancer Patients Eligible for Active Surveillance Benjamin I. Chung (Stanford University, USA)
10:30-10:45 Reliability of Negative Multiparametric MRI of the Prostate: Can We Avoid the Biopsy? Mark Frydenberg (Monash University, Australia)
10:45-11:00 Post Prostatectomy Incontinence – Assessment, Management and Local Results Stephen Mark (Christchurch Hospital and University of Otago, New Zealand)
11:00-11:15 A New Era of Asian Urology: a SWOT Analysis Rajeev Kumar (All India Institute of Medical Sciences, New Delhi, India)